Pharmacologic Management of Pediatric Hypertension.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 1, p. 31, doi. 10.1007/s40272-015-0151-3
- By:
- Publication type:
- Article
Works matching IS 11745878 AND DT 2016 AND VI 18 AND IP 1
Results: 8
1
2
Pharmacotherapy for Pediatric Generalized Anxiety Disorder: A Systematic Evaluation of Efficacy, Safety and Tolerability.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 1, p. 45, doi. 10.1007/s40272-015-0153-1
- By:
- Publication type:
- Article
3
Enhanced Paediatric Pharmacovigilance at the European Medicines Agency: A Novel Query Applied to Adverse Drug Reaction Reports.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 1, p. 55, doi. 10.1007/s40272-015-0154-0
- By:
- Publication type:
- Article
4
Recommendations Concerning the First-Line Treatment of Children with Tuberculosis.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 1, p. 13, doi. 10.1007/s40272-015-0155-z
- By:
- Publication type:
- Article
5
Tablet/Capsule Size Variation Among the Most Commonly Prescribed Medications for Children in the USA: Retrospective Review and Firsthand Pharmacy Audit.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 1, p. 65, doi. 10.1007/s40272-015-0156-y
- By:
- Publication type:
- Article
6
Prescribing Ceftolozane/Tazobactam for Pediatric Patients: Current Status and Future Implications.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 1, p. 1, doi. 10.1007/s40272-015-0157-x
- By:
- Publication type:
- Article
7
Zolmitriptan Nasal Spray: A Review in Acute Migraine in Pediatric Patients 12 Years of Age or Older.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 1, p. 75, doi. 10.1007/s40272-015-0160-2
- By:
- Publication type:
- Article
8
Emerging Agents for the Management of Nephrotic Syndrome: Progress to Date.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 1, p. 25, doi. 10.1007/s40272-015-0148-y
- By:
- Publication type:
- Article